Company Performance - Nu Skin Enterprises reported quarterly earnings of $0.21 per share, exceeding the Zacks Consensus Estimate of $0.18 per share, but down from $0.54 per share a year ago, indicating a 61.11% year-over-year decline [1] - The company achieved revenues of $439.08 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 2.11%, but down from $500.26 million in the same quarter last year, reflecting a 12.23% decrease [1] - Over the last four quarters, Nu Skin has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [1] Market Context - Nu Skin shares have declined approximately 46% since the beginning of the year, contrasting with the S&P 500's gain of 9% [2] - The current Zacks Rank for Nu Skin is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.48 on revenues of $465.7 million, and for the current fiscal year, it is $1.10 on revenues of $1.77 billion [4] - The cosmetics industry, to which Nu Skin belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, which may negatively impact stock performance [5] - Estee Lauder, a competitor in the same industry, is expected to report quarterly earnings of $0.25 per share, reflecting a year-over-year change of +257.1%, with revenues projected at $3.83 billion, up 6.3% from the previous year [5][6]
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Surpass Estimates